Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $25.7M |
| Sales growthchange from the year before | -3.6% |
| Gross marginshare of sales left after the direct cost of what it sells | -17.3% |
| Operating marginshare of sales left after running the business | -294.0% |
| Net marginshare of sales kept as profit | -292.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | -223.4% |
| Return on invested capitalprofit made on each $100 put into the business | -49.3% |
| Return on equityprofit vs. shareholders' accounting value | -163.2% |
| Debt / equitydebt vs. shareholders' accounting value | 1.63 |
| Interest coverhow many times profit covers interest payments | -296.0x |
| Change in share countnegative = the company is buying back its shares | +0.3% |
4 insiders sold $776K on the open market.
| Cornog William LDirector | SoldJul 31 | 216 shat $2.25 · $486 |
| Gruner KjellDirector | SoldJul 31 | 94,091 shat $2.11 · $199K |
| Gruner KjellDirector | SoldJul 30 | 7,071 shat $1.98 · $14K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy